Slideset: Early Induction Therapy for IBD

Learn about current guideline recommendations for the treatment of moderate to severe UC and CD, including the rationale for combination therapy.
Bruce E. Sands, MD, MS
Format: Microsoft PowerPoint (.ppt)
File Size: 581 KB
Released: April 26, 2021


Provided by Clinical Care Options

Contact Clinical Care Options

For customer support please email:

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by educational grants from
Bristol-Myers Squibb

Related Content

Video from Clinical Care Options (CCO) featuring expert insights into the whole-patient approach including treatment selection, common comorbidities, and coordination of care for patients with PsO/PsA.

April W. Armstrong, MD, MPH Philip Mease, MD, MACR Physicians: maximum of 1.0 AMA PRA Category 1 Credit Registered Nurses: 1.0 Nursing contact hour Released: August 27, 2021 Expired: August 26, 2022

Interactive video from Dr. Millie Long and Clinical Care Options (CCO) on new and emerging oral IBD therapies

Millie D. Long, MD, MPH Physicians: maximum of 0.25 AMA PRA Category 1 Credits Registered Nurses: 0.25 Nursing contact hours Released: August 24, 2021 Expired: August 23, 2022

Downloadable slides covering safety and efficacy data on new and emerging oral therapies for IBD, including S1PR modulators and JAK-STAT inhibitors.

Millie D. Long, MD, MPH Released: August 24, 2021

Expert commentary from Dr. Millie Long on the benefits of and barriers to patient participation in IBD clinical trials, from Clinical Care Options (CCO)

Millie D. Long, MD, MPH Released: August 17, 2021

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.